Health Care & Life Sciences » Biotechnology | Probiodrug AG

Probiodrug AG

Probiodrug AG
Stock Exchange Euronext - Alternext Amsterdam
EPS
 EUR0.95
Market Cap
 EUR23.41 M
Shares Outstanding
 8.19 M
Public Float
 4.72 M
Probiodrug AG
Stock Exchange Frankfurt Stock Exchange
EPS
 EUR0.94
Market Cap
 EUR44.21 M
Shares Outstanding
 8.21 M
Public Float
 -

Profile

Address
Weinbergweg 22
Halle Sachsen-Anhalt 06120
Germany
Employees -
Website http://www.probiodrug.de
Updated 07/08/2019
Probiodrug AG is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany.

Financials

View All
Created with Highcharts 5.0.14Probiodrug AGNet Income. Fiscal year is January-December. All values EUR Thousands.9 7579 75711 43711 43713 50513 50513 89113 8918 0098 0097 7377 73720132014201520162017201802.5k5k7.5k10k12.5k15k

Erich Maximilian Platzer
Chairman-Supervisory Board
Charlotte Lohmann
Member-Supervisory Board
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.